Katharine Yao to United States
This is a "connection" page, showing publications Katharine Yao has written about United States.
Connection Strength
1.386
-
Breast cancer trends and outcomes among young Black Women: A national cancer database analysis. Am J Surg. 2026 Jan; 251:116577.
Score: 0.092
-
Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures. Ann Surg Oncol. 2025 Oct; 32(11):8144-8155.
Score: 0.092
-
Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data. Ann Surg Oncol. 2025 Mar; 32(3):2045-2055.
Score: 0.088
-
Time From Screening to Treatment at Accredited Breast Centers in the United States. JCO Oncol Pract. 2025 Jun; 21(6):781-790.
Score: 0.088
-
Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID-19 pandemic. Cancer Med. 2024 01; 13(1):e6874.
Score: 0.082
-
Covid-19 related oncologist's concerns about breast cancer treatment delays and physician well-being (the CROWN study). Breast Cancer Res Treat. 2021 Apr; 186(3):625-635.
Score: 0.068
-
Impact of the Society of Surgical Oncology-American Society for Radiation Oncology Margin Guidelines on Breast-Conserving Surgery and Mastectomy Trends. J Am Coll Surg. 2019 07; 229(1):104-114.
Score: 0.059
-
Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat. 2019 Feb; 173(3):603-617.
Score: 0.058
-
Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075.
Score: 0.056
-
Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Breast J. 2017 Sep; 23(5):554-562.
Score: 0.052
-
Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676.
Score: 0.051
-
National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. J Am Coll Surg. 2017 Mar; 224(3):236-244.
Score: 0.051
-
Trends and variation in the use of nipple-sparing mastectomy for breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):111-120.
Score: 0.050
-
Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making. Ann Surg Oncol. 2016 10; 23(10):3106-11.
Score: 0.049
-
Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes. J Surg Oncol. 2015 Dec; 112(8):809-14.
Score: 0.047
-
Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):187-96.
Score: 0.045
-
Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer. J Am Coll Surg. 2015 Jul; 221(1):71-81.
Score: 0.045
-
Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010. JAMA Surg. 2014 Dec; 149(12):1296-305.
Score: 0.044
-
Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015 Mar; 22(3):899-907.
Score: 0.043
-
Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012 Nov; 215(5):658-66; discussion 666.
Score: 0.038
-
Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010 Oct; 17(10):2554-62.
Score: 0.032
-
Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer. JAMA Netw Open. 2024 05 01; 7(5):e249449.
Score: 0.021
-
A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic. Cancer. 2022 06 01; 128(11):2119-2125.
Score: 0.018
-
The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis. J Surg Oncol. 2018 Jul; 118(1):212-220.
Score: 0.014
-
Facility-level analysis of robot utilization across disciplines in the National Cancer Database. J Robot Surg. 2019 Apr; 13(2):293-299.
Score: 0.014
-
Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer. Otolaryngol Head Neck Surg. 2018 02; 158(2):303-308.
Score: 0.013
-
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. JAMA Oncol. 2017 Jul 01; 3(7):928-935.
Score: 0.013
-
Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. Breast Cancer Res Treat. 2017 04; 162(2):317-328.
Score: 0.013
-
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol. 2016 10; 23(10):3100-5.
Score: 0.012
-
Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46.
Score: 0.012
-
Advanced Age Does Not Worsen Recovery or Long-Term Morbidity After Postmastectomy Breast Reconstruction. Ann Plast Surg. 2016 Feb; 76(2):164-9.
Score: 0.012
-
The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. Ann Surg Oncol. 2015 Oct; 22(11):3474-80.
Score: 0.011